Way of linking the biological sample to the collection and / or information related to the biological sample in the collection with information from biological samples THIS DONOR

摘要

1.method u0441u0432u00a0u0437u044bu0432u0430u043du0438u00a0 biological sample collection and / or information u043eu0442u043du043eu0441u00a0u0449u0435u0439u0441u00a0 biological sample collection, with information about the donor of the biological samples s, including a public inquiry or u0437u0430u00a0u0432u043au0443 information about donors of biological samples in the collection, determining one or more biological characteristics of dong ora, a request, or u0437u0430u00a0u0432u043au0435 informationthe provision of certain biological characteristics of the donor, together with information about the donor or the owner of the collection, comparison, oda u0435u0434u0435u043bu0435u043du043du044bu0445 biological characteristics of the donor with the relevant biological characteristics identification of biological samples u0434u043bu00a0 biologist u0438u0447u0435u0441u043au043eu0439 samples of donor and / or informationu043eu0442u043du043eu0441u00a0u0449u0435u0439u0441u00a0 to the biological sample, and u0441u0432u00a0u0437u044bu0432u0430u043du0438u0435 information about the donor with his or her biological sample and / or information u043eu0442u043du043eu0441u00a0u0449u0435u0439u0441u00a0 to this sample.;2. method for u0438u043du0444u043eu0440u043cu0430u0446u0438u00a0 1, in which the donor u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 an objection or consent to the use of biological samples and / or data, cc u043eu0441u00a0u0449u0435u0439u0441u00a0 biological sample.;3. method for u0438u043du0444u043eu0440u043cu0430u0446u0438u00a0 1, in which the donor u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 additional information u043eu0442u043du043eu0441u00a0u0449u0443u044eu0441u00a0 to the donor and / or his or e e the biological sample.;4. method for article 3, in which u0434u043eu043fu043eu043bu043du0438u0442u0435u043bu044cu043du0430u00a0 u0438u043du0444u043eu0440u043cu0430u0446u0438u00a0 selected from the group u0441u043eu0441u0442u043eu00a0u0449u0435u0439 from history, u0433u0435u043du0435u0430u043bu043eu0433u0438u0447u0435u0441u043au043eu0439 information, information on lifestyle, information iic source, information environment, epidemiological information, social information, ethnic information, demographic information, and x u0441u043eu0447u0435u0442u0430u043du0438u00a0.;5. method for u0438u043du0444u043eu0440u043cu0430u0446u0438u00a0 1, in which the donor u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a request for information, u043eu0442u043du043eu0441u00a0u0449u0443u044eu0441u00a0 to his or her biological sample.;6. method according to clause 5, in which a request for information, u043eu0442u043du043eu0441u00a0u0449u0443u044eu0441u00a0 biological sample includes a request for information about the propensity to u0437u0430u0431u043eu043bu0435u0432u0430u043du0438u00a0u043c, u0434u0438u0430u0433u043du043eu0441u0442u0438u0447u0435u0441 do information, predictive information, information on the genetic u0437u0430u0431u043eu043bu0435u0432u0430u043du0438u00a0u0445, information about the disease (u00a0u0445), (u0430u043du0442u0440u043eu043fu043e) genetic information other medical information, general information and / or their u0441u043eu0447u0435u0442u0430u043du0438u00a0.;7. method for 1, in which a sample of the u0431u0438u043eu043bu043eu0433u0438u0447u0435u0441u043au0430u00a0 u00a0u0432u043bu00a0u0435u0442u0441u00a0 biological sample.;8. method for u0431u0438u043eu043bu043eu0433u0438u0447u0435u0441u043au0430u00a0 p.7, in which the sample is selected from the group u0441u043eu0441u0442u043eu00a0u0449u0435u0439 of body part, organ, tissue, placenta, u043fu0443u043fu043eu0447u043du043eu0433u043e u043au0430u043du0430u0442u0438u043au0430, whole blood, fluid u043eu0440u0433u0430u043du0438u0437 ma, u0441u0435u043au0440u0435u0442u0438u0440u043eu0432u0430u043du043du043eu0439 fluid cells (cr), u0432u043du0443u0442u0440u0438u043au043bu0435u0442u043eu0447u043du043eu0439 organelles (u043bu043b), u0432u043du0443u0442u0440u0438u043au043bu0435u0442u043eu0447u043du043eu0433u043e component (s) of cell membranes (n), u0432u043du0435u043au043bu0435u0442u043eu0447u043du043eu0433u043e u043cu0430u0442u0440u0438u043au0441u0430, u0432u043du0435u043au043bu0435u0442u043eu0447u043d wow component (s), the product (s) cell cultures and their u0441u043eu0447u0435u0442u0430u043du0438u00a0.;9. method for 1, in which a public inquiry or u0437u0430u00a0u0432u043au0438 to information about the donor is selected from the group u0441u043eu0441u0442u043eu00a0u0449u0435u0439 of u0442u0435u043bu0435u0432u0438u0434u0435u043du0438u00a0, text tv, the internet, u043eu043fu0440u0435u0434 u0435u043bu0435u043du043du043eu0439 network (it), internet, lan, wan, email, phone, sms, radio, newspapers, magazines, billboards, leaflets, mailing, posters, notices and together u0442u0430u043du0438u0439.;10. method for p.1, where biological characteristics selected from the group u0441u043eu0441u0442u043eu00a0u0449u0435u0439 types "fingerprints" of dna length polymorphism types of reaction product of poly (RELP) u043cu0435u0440u0430u0437u043du043eu0439 chain reaction (pcr) products with an r.l.f.t.... in real-time (u043au0442u043fu0446u0440), types of gene expression, protein expression, u043fu043eu043bu0438u043cu043eu0440u0444u0438 ism one u043du0443u043au043bu0435u043eu0442u0438u0434u0430 (SNP), structures of rna like levels of rna.genomic mutations, genomic u0434u0435u043bu0435u0446u0438u0439, genomic inserts, the genome of cellular composition, morphology of cells, the composition of the blood, the fluid delivery system. wa tissue morphology of the tissue composition of the u0432u043du0435u043au043bu0435u0442u043eu0447u043du043eu0433u043e u043cu0430u0442u0440u0438u043au0441u0430, morphology u0432u043du0435u043au043bu0435u0442u043eu0447u043du043eu0433u043e u043cu0430u0442u0440u0438u043au0441u0430, structures of protein concentrations protein lipid structures, concen nations of lipids, carbohydrates, carbohydrate concentrations.structures u043fu0440u043eu0442u0435u043eu0433u043bu0438u043au0430u043du043eu0432, concentrations of u043fu0440u043eu0442u0435u043eu0433u043bu0438u043au0430u043du043eu0432, structures of glycoproteins in glycoproteins structures u0433u043bu0438u043au043eu043bu0438u043fu0438u0434u043eu0432, concentrations of u0433u043bu0438u043au043eu043bu0438u043fu0438u0434u043eu0432, structures u043bu0438u043fu043eu043fu0440u043eu0442u0435u0438u043du043eu0432, concentrations of u043bu0438u043fu043eu043fu0440u043eu0442u0435u0438u043du043eu0432, structures of nucleotides, nucleotide concentrations and their combinations.;11. method for 1, in which u0438u043du0444u043eu0440u043cu0430u0446u0438u00a0 includes a certificate to the effect that some biological characteristics of the u043fu0440u043eu0438u0441u0445u043eu0434u00a0u0442 from the donor.;12. method for 1, in which u0438u043du0444u043eu0440u043cu0430u0446u0438u00a0 contains identification of the donor.;13. method for 1, in which the u0438u043du0444u043eu0440u043cu0430u0446u0438u00a0 u043fu0440u0435u0434u043eu0441u0442u0430u0432u043bu00a0u0435u0442u0441u00a0 or owner collection through an intermediary.;14. way on p.13, which the mediator is selected from the group u0441u043eu0441u0442u043eu00a0u0449u0435u0439 from doctors, family doctors, nurses, medical officer, lawyer, notary, and u0443u043fu043eu043bu043du043eu043cu043eu0447u0435u043du043d wow u043fu0440u0435u0434u0441u0442u0430u0432u0438u0442u0435u043bu00a0.;15. method u043eu0431u0435u0441u043fu0435u0447u0435u043du0438u00a0 information u043eu0442u043du043eu0441u00a0u0449u0435u0439u0441u00a0 biological sample, u043du0430u0445u043eu0434u00a0u0449u0435u0439u0441u00a0 collection, a biological samples, including the implementation of the method for the same mu of u043fu043f.1 - 14 and ensuring the donor information, u043eu0442u043du043eu0441u00a0u0449u0435u0439u0441u00a0 to his or her biological sample.;16. method for u0438u043du0444u043eu0440u043cu0430u0446u0438u00a0 p.15, which is selected from the group u0441u043eu0441u0442u043eu00a0u0449u0435u0439 from information on the susceptibility to disease (u00a0u043c), diagnostic information, u043fu0440u043eu0433u043du043eu0441u0442u0438u0447u0435u0441u043a ow of information, information on the inheritance disease (u00a0u0445), information about the disease (u00a0u0445), (u0430u043du0442u0440u043eu043fu043e) genetic information, other medical inform stock, common information, and their combinations.;17. method for p.15 or 16, in which the u0438u043du0444u043eu0440u043cu0430u0446u0438u00a0, u043eu0442u043du043eu0441u00a0u0449u0430u00a0u0441u00a0 biological sample, u043fu0440u0435u0434u043eu0441u0442u0430u0432u043bu00a0u0435u0442u0441u00a0 through an intermediary.;18. way to p.17, in which the mediator is selected from the group u0441u043eu0441u0442u043eu00a0u0449u0435u0439 from doctors, family doctors, nurses, medical officer, lawyer, notary, and u0443u043fu043eu043bu043du043eu043cu043eu0447u0435u043du043d wow u043fu0440u0435u0434u0441u0442u0430u0432u0438u0442u0435u043bu00a0.